Abstract
Progress toward hepatitis C virus (HCV) elimination in the United States is not on track to meet targets, as injection drug use continues to drive increasing HCV incidence. Computational models are useful in understanding the complex interplay of individual, social, and structural level factors that might alter HCV incidence, prevalence, transmission, and disease progression. However, these models need to be informed with real socio-behavioral data. We conducted a meta-analysis of research studies spanning 20 years of research and interventions with people who inject drugs in metropolitan Chicago to produce parameters for a synthetic population for a computational model. We then fit an exponential random graph model (ERGM) using the network estimates from the meta-analysis in order to develop the dynamic component of a realistic agent-based model.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a grant to HD and BB from the National Institute of General Medical Sciences [grant number R01GM121600]. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was determined to be exempt by the University of Illinois at Chicago IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Supplemental files updated
Data Availability
Data are available on Open Science Framework
